Lv4
663 积分 2021-08-11 加入
The DNA damage response and cancer immunotherapy
27天前
已完结
Deep-learning-based HER2 status assessment from multimodal breast cancer data predicts neoadjuvant therapy response
3个月前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
4个月前
已完结
Integrated Genomic Profiling Identifies Predictive Biomarkers for Neoadjuvant Therapy Response in Chinese Breast Cancer Patients
4个月前
已完结
Cellular neighborhoods in cancer
5个月前
已完结
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
11个月前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
1年前
已完结
Trastuzumab deruxtecan or ramucirumab plus paclitaxel in gastric cancer
1年前
已完结
皖公网安备34019202002308
